2[1]Clodi M,Oberbauer R,Bodlaj G, et al.Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients.Metabolism,1999,48(3):369-372
3[2]Nakagawa H,Kida Y,Sakamoto K,et al.Relationship between the stage of diabetic nephropathy and serum lipoprotein(a) concentrations-influence of hypoproteinemia.Nippon Jinzo Gakkai Shi,1996,38(11):513-518
4[3]Kronenberg F,Trenkwalder E,Lingenhel A,et al.Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp[a] from the renal circulation.J Lipid Res,1997,38(9):1755-1763
6Ceriello A,Taboga C,Giacomello R et al.Fibringoen plasma levels as a marker of thrombin activation in diabetes. Diabetes . 1994
7Tripodi A,Mannucci P M.Markers of activated coagulation and their usefulness in the clinical laboratory. Clinical Chemistry . 1996
8Falleti E.Fibrinogen plasma levels as a marker of thrombin activation: new insights of the role of fibrinogen as a cardiovascular risk factor. Thrombosis and Haemostasis . 1994
9Lee A J,Low G D O,Woodard M et al.Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. British Heart Journal . 1993
10Cortellaro M,Boschetti C,Cofrancesco E.The PLAT study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis . 1991
